Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed 2021-09-10 Acc 0001209191-21-055483

Director bought 882 shares at an average $2.98 ($2,627)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Jones James Director	2021-08-02	Purchase	+42	$3.34	$140	15,456	D
Jones James Director	2021-08-03	Purchase	+42	$3.17	$133	15,498	D
Jones James Director	2021-08-04	Purchase	+42	$3.18	$134	15,540	D
Jones James Director	2021-08-05	Purchase	+42	$3.11	$131	15,582	D
Jones James Director	2021-08-06	Purchase	+42	$3.01	$126	15,624	D
Jones James Director	2021-08-09	Purchase	+42	$2.93	$123	15,666	D
Jones James Director	2021-08-10	Purchase	+42	$2.96	$124	15,708	D
Jones James Director	2021-08-11	Purchase	+42	$2.98	$125	15,750	D
Jones James Director	2021-08-13	Purchase	+42	$2.92	$123	15,792	D
Jones James Director	2021-08-16	Purchase	+42	$2.92	$123	15,834	D
Jones James Director	2021-08-17	Purchase	+42	$3.05	$128	15,876	D
Jones James Director	2021-08-18	Purchase	+42	$2.97	$125	15,918	D
Jones James Director	2021-08-19	Purchase	+42	$3.02	$127	15,960	D
Jones James Director	2021-08-20	Purchase	+42	$2.96	$124	16,002	D
Jones James Director	2021-08-23	Purchase	+42	$2.87	$121	16,044	D
Jones James Director	2021-08-24	Purchase	+42	$2.89	$121	16,086	D
Jones James Director	2021-08-25	Purchase	+42	$2.79	$117	16,128	D
Jones James Director	2021-08-26	Purchase	+42	$2.82	$118	16,170	D
Jones James Director	2021-08-27	Purchase	+42	$2.84	$119	16,212	D
Jones James Director	2021-08-30	Purchase	+42	$2.88	$121	16,254	D
Jones James Director	2021-08-31	Purchase	+42	$2.93	$123	16,296	D
Open-market purchases · 882 sh · avg $2.98 · $2,627